Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. - Wikidata - awgldk - TriplyDB

Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.

Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.

http://www.wikidata.org/entity/Q42679580

about

Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma Tumor immunotargeting using innovative radionuclides Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell c Solid renal masses: what the numbers tell us.Management of urological malignancies: Has positron emission tomography/computed tomography made a difference?Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.Fabrication of mAb G250-SPIO molecular magnetic resonance imaging nanoprobe for the specific detection of renal cell carcinoma in vitro PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.Challenges in RCC Imaging: Renal Insufficiency, Post-Operative Surveillance, and the Role of Radiomics.Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT.Molecular imaging of urogenital diseases.Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.Immuno-PET for Clinical Theranostic Approaches.[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma.Active surveillance of small renal masses.Molecular imaging and carbonic anhydrase IX-targeted radioimmunotherapy in clear cell renal cell carcinoma.Engineered antibodies for molecular imaging of cancer.The role of imaging in the active surveillance of small renal masses.Osteoblastic bone metastases from renal cell carcinoma.Nuclear medicine in urological cancers: what is new?Evolving role of positron emission tomography (PET) in urological malignancy.Radiopharmaceuticals as probes to characterize tumour tissue.Post partial nephrectomy surveillance imaging: an evidence-based approach.Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial.Nuclear imaging of renal tumours: a step towards improved risk stratification.Next revolution in molecular theranostics: personalized medicine for urologic cancers.ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice.Renal cell carcinoma: the search for a reliable biomarker.Characterization of indeterminate renal masses with molecular imaging: how do we turn potential into reality?Targeting ion transport in cancer ImmunoPET to help stratify patients for targeted therapies and to improve drug development.Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX.Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetect A Dual Reporter Iodinated Labeling Reagent for Cancer Positron Emission Tomography Imaging and Fluorescence-guided Surgery.PET-CT and PET-MR in urological cancers other than prostate cancer: An update on state of the art.I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma.Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteers.Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study.

P2860

Q27026961-2FF33C0B-1B43-436A-BA35-F7EB2769B3F8 Q28083230-47F4B8EB-0206-49FD-B082-B0E1AEC59A74 Q33995700-94BBC280-67C5-4E66-AD6F-A4159C0097B3 Q34241434-B768103F-176E-42B5-81AD-03EDF03DCC87 Q34990800-6B2B20B2-4C92-4B50-B65C-1316A352AA88 Q35152565-62CE438B-B8C3-4003-BCA7-4D3DB8C992B7 Q35202263-D6C06BCE-EB19-443F-A98F-A5A40D801827 Q35776939-DA947ABE-D35F-40A7-B81B-4DFACBAB9A12 Q36628918-AFFE6561-7131-4E9E-8C2C-6DB1BB433763 Q36961767-A8B0E27D-D19F-4BF9-9478-B18C4632F467 Q37550399-E73F76F9-8808-4DD2-8B01-179EF135E2E5 Q37554230-4051163C-E8B7-4D00-84D7-1BC9D8D4B498 Q37631461-30DCB1DB-3007-4EF4-8A93-4D406D175E37 Q37636649-54EEFD17-A787-4036-AEE0-AF0974959E3D Q38097280-8498776D-E56B-46E8-AF16-F6542D8F53D9 Q38103580-411A21A9-0B5D-416E-858F-32D1D046EBDD Q38148881-37E5B9A6-16D2-4D13-8FF2-9E87C762883A Q38178123-29B59CA3-9B41-4CBF-9AB5-7EF6A6CE826B Q38245224-F83872E1-5781-47DB-986B-8C2C8B64F7D2 Q38268168-1F1092C5-E609-4A7B-9E33-A6AF1D5225A6 Q38269763-788A0C56-B63F-4FBD-A89E-B960D70448C7 Q38342458-94EF1931-1BCB-4D21-94E2-EDD9177623AF Q38370142-CF175E31-BD1D-47D3-8AE8-94DEBF467D45 Q38385722-357F5BFF-C8DE-4C28-8D66-E3790FA07D24 Q38521920-2FA15481-52F5-4B99-B675-3F30F28211B8 Q38559336-DB71833A-4391-4002-A259-69B4F2454B0F Q39148640-5D8EBCD3-579F-4BC2-999E-1902B432424C Q41197945-008DB6ED-E70B-44D2-905D-02E0CA266420 Q41871815-E8B1364A-799A-438C-982C-61C6FC6FC452 Q41930187-1499DB83-9998-47E8-B65E-B412E4593194 Q42388200-5B1E351C-FF3A-4821-AB3F-E842F20B6C7A Q47097799-3121395F-5E53-49E4-B5EF-B50463042BB8 Q47935784-5AE5BB58-CE99-44CD-8461-7FDD24490F6A Q48125631-097F6B7B-74D0-4637-9E4D-4D1CBAD1A406 Q49165684-8C5F8A8B-10CB-4C0B-94BC-1CC0F9E6EE9F Q52672750-37BEA92A-51BA-48D7-80CB-07DF63B63F2E Q53072001-A0257A22-C824-4371-9853-E115D4F7CC8E Q55156515-D3FD1265-BA11-4757-9E4A-52C44D11B31E

P2860

Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.

http://www.wikidata.org/entity/Q42679580

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Positron emission tomography/c ...... results from the REDECT trial.

@en

Positron emission tomography/c ...... results from the REDECT trial.

@nl

type

label

Positron emission tomography/c ...... results from the REDECT trial.

@en

Positron emission tomography/c ...... results from the REDECT trial.

@nl

prefLabel

Positron emission tomography/c ...... results from the REDECT trial.

@en

Positron emission tomography/c ...... results from the REDECT trial.

@nl

P1433

Q42679580-7C23E031-F869-400A-BD6C-D99F2671F882

P1476

Q42679580-27A62A34-A8BF-40D6-B1E3-7EFBA341C164

P2093

Q42679580-035A1C89-C131-4A42-B0AF-3B8C0D406949

Q42679580-2EC760B4-2D61-468F-81D6-6B82A5A998FE

Q42679580-409208B3-4471-4753-8277-5B9890B7C228

Q42679580-40AFF0D6-176C-4D46-9B2F-267E39C7024D

Q42679580-42DC2399-D059-4A43-B990-F41725B9E946

Q42679580-8958A122-1297-4425-AF19-ED716F812888

Q42679580-9B8C618C-712D-4873-AFDE-49853AA3C33D

Q42679580-CBEEFD3C-5BC7-42E5-8198-732EAAB38B12

Q42679580-D3CD4411-36A0-46C9-88C9-0462909D4728

Q42679580-EB6D41F3-1B15-4A5E-9343-1B8D7C704662

P2860

Q42679580-0077B815-26D9-4C6B-9204-3445FBB3AC6E

Q42679580-052D1DDE-5684-4EE0-8B88-EEFBF1392FEA

Q42679580-06AE1FD0-2F34-4013-8EB4-F0BA10D37D31

Q42679580-08C2D9B4-55BE-4D01-8894-367993F63731

Q42679580-0F2D1CE6-0FE5-417D-AC90-229F4DBDAD50

Q42679580-14D2B3F2-A598-4256-8D87-CCF532E46C5D

Q42679580-15932C6E-BE25-41C9-B66E-625DDC1828C1

Q42679580-1A4506A6-666E-454F-95DD-9D1F8DC8CD05

Q42679580-25702BBB-C4A0-4F95-AAB6-DFFD17AE2E94

Q42679580-28B716D0-0CDA-4A5C-9404-BCC39B98BCDB

P304

Q42679580-5F2C95E3-5558-49FA-9AAA-671DF4611800

P31

Q42679580-94F729B2-1534-4E78-AD2E-AFB3748CF5FD

P356

Q42679580-F64676B6-AFD9-404B-ABD9-486FD8FDEB8A

P407

Q42679580-9843F304-95C0-4E18-84F2-794C7DD64B02

P433

Q42679580-D82FEFC0-8E01-45D7-992A-B17537999FA9

P478

Q42679580-F4301F2F-B8A5-4C97-8202-5DFC45C92E15

P50

Q42679580-F4E93450-5465-4B72-8C9B-E70181FFB562

P577

Q42679580-1DDB8D93-AB8C-4670-8896-B81618D435DE

P5875

Q42679580-05BC54FF-01E5-4E40-A39B-6163641BB612

P698

Q42679580-4C8FCDFB-90F8-4492-9D59-F4A26CBE52E6

P932

Q42679580-DF42D016-D149-496C-9CD4-7FD68C413B73

P356

JCO.2011.41.2445

P1433

Journal of Clinical Oncology

P1476

Positron emission tomography/c ...... results from the REDECT trial.

@en

P2093

Chaitanya R Divgi

http://www.w3.org/2001/XMLSchema#string

Constantine Gatsonis

http://www.w3.org/2001/XMLSchema#string

David Chen

http://www.w3.org/2001/XMLSchema#string

Jian Qin Yu

http://www.w3.org/2001/XMLSchema#string

Paul Bevan

http://www.w3.org/2001/XMLSchema#string

Paul Russo

http://www.w3.org/2001/XMLSchema#string

Robert G Uzzo

http://www.w3.org/2001/XMLSchema#string

Roman Bartz

http://www.w3.org/2001/XMLSchema#string

Silke Treutner

http://www.w3.org/2001/XMLSchema#string

Steven Larson

http://www.w3.org/2001/XMLSchema#string

P2860

The Measurement of Observer Agreement for Categorical Data

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses.

Clinical practice. Small renal mass.

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience.

Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?

Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology.

Renal mass biopsy--a renaissance?

Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis

P304

187-194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2011.41.2445

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Jorge A. Carrasquillo

P577

2012-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233849858

http://www.w3.org/2001/XMLSchema#string

P698

23213092

http://www.w3.org/2001/XMLSchema#string

P932

5795663

http://www.w3.org/2001/XMLSchema#string